Automated analysis of FDG PET as a tool for single-subject probabilistic prediction and detection of Alzheimer’s disease dementia

Summary Metrics to Assess Alzheimer Disease-Related Hypometabolic Pattern with 18F-FDG PET: Head-to-Head Comparison

(2012) A. Caroli et al.   JOURNAL OF NUCLEAR MEDICINE

Resting metabolic connectivity in prodromal Alzheimer's disease. A European Alzheimer Disease Consortium (EADC) project

(2012) Silvia Morbelli et al.   NEUROBIOLOGY OF AGING

Correlations between FDG PET glucose uptake-MRI gray matter volume scores and apolipoprotein E ε4 gene dose in cognitively normal adults: A cross-validation study using voxel-based multi-modal partial least squares

(2012) Kewei Chen et al.   NEUROIMAGE

Predicting Cognitive Decline in Subjects at Risk for Alzheimer Disease by Using Combined Cerebrospinal Fluid, MR Imaging, and PET Biomarkers

(2012) Jennifer L. Shaffer et al.   RADIOLOGY

The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Guy M. McKhann et al.   Alzheimers & Dementia

The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Marilyn S. Albert et al.   Alzheimers & Dementia

The Alzheimer’s Disease Neuroimaging Initiative: A review of papers published since its inception

(2011) Michael W. Weiner et al.   Alzheimers & Dementia

Functional implications of hippocampal degeneration in early Alzheimer’s disease: a combined DTI and PET study

(2011) Igor Yakushev et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Effectiveness and Safety of 18F-FDG PET in the Evaluation of Dementia: A Review of the Recent Literature

(2011) N. I. Bohnen et al.   JOURNAL OF NUCLEAR MEDICINE

Evaluation of a Calibrated 18F-FDG PET Score as a Biomarker for Progression in Alzheimer Disease and Mild Cognitive Impairment

(2011) K. Herholz et al.   JOURNAL OF NUCLEAR MEDICINE

Dementia: new criteria but no new treatments

(2011) Reisa A Sperling et al.   LANCET NEUROLOGY

Characterizing Alzheimer's disease using a hypometabolic convergence index

(2011) Kewei Chen et al.   NEUROIMAGE

APOE4 is associated with greater atrophy of the hippocampal formation in Alzheimer's disease

(2011) Michela Pievani et al.   NEUROIMAGE

MCI Patients Declining and Not-Declining at Mid-Term Follow-Up: FDG-PET Findings

(2010) M. Pagani et al.   Current Alzheimer Research

New Research Criteria for the Diagnosis of Alzheimer’s Disease Applied in a Memory Clinic Population

(2010) F.H. Bouwman et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Revising the definition of Alzheimer's disease: a new lexicon

(2010) Bruno Dubois et al.   LANCET NEUROLOGY

Comparing predictors of conversion and decline in mild cognitive impairment

(2010) S. M. Landau et al.   NEUROLOGY

Brain Glucose Metabolism in Vascular White Matter Disease With Dementia

(2010) Belen Pascual et al.   STROKE

MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers

(2009) N. Schuff et al.   BRAIN

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

(2009) Clifford R Jack et al.   LANCET NEUROLOGY

Multimodal techniques for diagnosis and prognosis of Alzheimer's disease

(2009) Richard J. Perrin et al.   NATURE

Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI

(2009) Susan M. Landau et al.   NEUROBIOLOGY OF AGING

Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease

(2009) A. Drzezga et al.   NEUROLOGY

Cortical Atrophy and Language Network Reorganization Associated with a Novel Progranulin Mutation

(2008) Carlos Cruchaga et al.   CEREBRAL CORTEX

CSF and MRI markers independently contribute to the diagnosis of Alzheimer's disease

(2007) Niki S.M. Schoonenboom et al.   NEUROBIOLOGY OF AGING